|
|
|
Volumn 19, Issue 2, 2007, Pages 163-169
|
|
Concurrent cisplatin/radiation followed by adjuvant cisplatin/paclitaxel in treatment of patients with stage IB grade 3, IC and IIA endometrial carcinoma.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
PACLITAXEL;
ADJUVANT CHEMOTHERAPY;
AGED;
ARTICLE;
CANCER INVASION;
CANCER STAGING;
ENDOMETRIUM TUMOR;
FEASIBILITY STUDY;
FEMALE;
FOLLOW UP;
HUMAN;
HYSTERECTOMY;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
OVARIECTOMY;
PATHOLOGY;
PROGNOSIS;
RADIATION DOSE;
SURVIVAL RATE;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COMBINED MODALITY THERAPY;
ENDOMETRIAL NEOPLASMS;
FEASIBILITY STUDIES;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYSTERECTOMY;
MIDDLE AGED;
NEOPLASM INVASIVENESS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
OVARIECTOMY;
PACLITAXEL;
PROGNOSIS;
RADIOTHERAPY DOSAGE;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 61549122429
PISSN: 11100362
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
